Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04908475 |
|---|---|
| Brief Title: | Study of Subcutaneous Risankizumab Injection Compared to Oral Apremilast Tablets to Assess Change in Disease Activity And Adverse Events in Adult Participants With Moderate Plaque Psoriasis Who Are Candidates for Systemic Therapy |
| First Submitted : | May 28, 2021 |
| First Submitted that Met QC Criteria : | May 28, 2021 |
| First Posted : | June 1, 2021 |
| Results First Submitted : | April 2, 2024 |
| Results First Submitted that Met QC Criteria : | April 2, 2024 |
| Results First Posted : | April 30, 2024 |
| Last Update Submitted that Met QC Criteria : | April 2, 2024 |
| Last Update Posted : | April 30, 2024 |